Medical Devices
Early stage

Renephra are developing an innovative medical device to treat patients of chronic oedema and fluid overload. Heart failure patients with chronic oedema and fluid overload can be very challenging to treat and Renephra's technology has the potential to be much more convenient and enabling for patients as well as offer very significant savings for healthcare providers by enabling treatment in the community and home setting. Renephra's solution is to remove excess fluid through the skin using disposable microneedle patches.

Renephra is a spin out company from the University of Manchester and Manchester University NHS Foundation Trust, has a well-defined clinical need, established clinical proof of principle and clear route for commercialisation.

Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Nick Wright


view complete team

Contact us

Tel: 01625 344300